AN2 Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2023
Filed with the SEC on May 14, 2024 and accepted by EDGAR at May 14, 2024, 20:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-24-059488. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.